Menu

Marc TROMBE

PARIS

Electionseuropéennes 2024

RETROUVEZ GRATUITEMENTLe résultat des européennes à Paris.

En résumé

After 10 years working in the field of tumour micro-environment in academical labs, start up and industry, I have joined the Oncology department of Sanofi-Aventis.
It is fascinating get into this field full of genetic, mutation and gene amplification and chromosomal instability.
I still have the same dream: contribute significantly to something which will improve healthcare

Mes compétences :
Biochemistry

Entreprises

  • Sanofi -Aventis/R&D biothérapeutics - Research Scientist

    2007 - maintenant Management of a team with 2 technicians and one student
    Leading 1 research project on the generation of antibodies to target colon cancer
    3 patents (2003, 2004, 2008), one publication in gene and dev (2007), two prices in international meetings (first in fundamental research, Eurocancer paris 2002 and second in fundamental research international meeting in angiogenesis, Leiden 2003)

  • Collège de France, Paris - Post Doc

    2005 - 2006 Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis. Trombe et al, Gene and Development Nov 2007

  • Sanofi -Aventis - Post-Doc

    Paris 2004 - 2005 Target validations

  • Abtech Pharma, Dir Alain Guédon - PhD

    2000 - 2003 PhD: Development of anti-Idiotypic antibodies targeting selectively VEGF-R1 or VEGF-R2 and determination of 4-7 Ig like domains of VEGF-R2 in angiogenesis mechanisms, Dir Dr Jean Plouët

Formations

  • Université Paris 11 Paris Sud

    Orsay 1998 - 1999 Biology

    iNOS activation by cytokine and interferon in Ewing sarcoma, Dir Dr Jeanne Wietzerbin

    DEA structure et fonctionnement des systèmes biolgiques intégrés

  • King'S College London (Londres)

    Londres 1997 - 1998 Biochimie-Biologie cellulaire-Immunologie

    Maitrise de Biochimie/Biologie Cellulaire ERASMUS

Réseau

Annuaire des membres :